Mirae Asset Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹949 Cr | ₹2313 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 10 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 15% |
| Expense Ratio | 2.21 | 1.97 |
| Manager | Meeta Shetty | Vrijesh Kasera |
| ISIN Code | INF277K016A9 | INF769K01EA2 |
| Exits Load | Exit load of 0.25% if redeemed within 30 days./365 | I. For investors who have opted for SWP under the plan: a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil. b) Any redemption in excess of such limits in the first 365 d/365 |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | 7.23% | 7.31% |
| 6 Month | 21.76% | 24.02% |
| 1 Year | 52.93% | 49.91% |
| 3 Year | 19.75% | 18.14% |
| 5 Year | 28.8% | 31.01% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 17.22% | 15.59% |
| 3 Year | 42.6% | 37.14% |
| 5 Year | 77.31% | 75.98% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 6.62% | 23.05% |
| 3 Year | 17.45% | 21.06% |
| 5 Year | 14.18% | 23.92% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.23% | 14.65% |
| Sharp | 0.74% | 0.62% |
| Beta | 0.9% | 0.95% |
| Alpha | 2.85% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Meeta Shetty | Vrijesh Kasera |
| Total AUM | ₹17847 Cr | ₹12061 Cr |
| Fund Manage | 5 | 4 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 5.34 | 0.45 |
| Small Cap | 16.33 | 12.72 |
| Mid Cap | 39.68 | 40.25 |
| Large Cap | 38.65 | 46.58 |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 3.05 | 0.44 |
| Healthcare | 93.35 | 97.47 |
| Chemicals | 1.31 | 0.82 |
| Services | 2.29 | - |
| Financial | - | 1.26 |
| Unclassified | - | 0.01 |
Top Comparisons
Franklin India Banking & PSU Debt Fund - Growth
3Y Returns5.44%
Nippon India Banking & PSU Debt Fund- Growth Plan- Growth Option
3Y Returns5.49%
Kotak Overnight Fund -Regular plan-Growth Option
3Y Returns5.54%
UTI - Overnight Fund - Regular Plan - Growth Option
3Y Returns5.6%
Nippon India Passive Flexicap FoF - Regular Plan - Growth Option
3Y Returns18.57%
Tata Gold ETF Fund of Fund - Regular (G)
3Y Returns0%
Kotak Healthcare Fund - Regular (G)
3Y Returns0%
HDFC Pharma and Healthcare Fund - Regular (G)
3Y Returns0%